Articles > Newspapers > International Newspapers, Local Markets A-Lh > AsiaPulse News news wires > September 2008

Article: BRIEFING - ASIA HEALTH - SEPT 2, 2008.

Article from:
AsiaPulse News
Article date:
September 2, 2008
Copyright

An executive briefing on Health for Sept 2, 2008, prepared by Asia Pulse (http://www.asiapulse.com), the real-time, Asia-based wire with exclusive news, commercial intelligence and business opportunities.

SHIONOGI TO ACQUIRE U.S. DRUGMAKER SCIELE PHARMA FOR US$1.4 BLN

OSAKA - Shionogi & Co. (TSE:4507) on Monday announced plans to acquire U.S. firm Sciele Pharma Inc. for US$1.42 billion, or about 150 billion yen, as part of efforts to bolster its sales network in the world's largest pharmaceutical market.

In a tender offer to start within 10 business day, the Japanese company will solicit all outstanding shares for US$31.00 apiece -- a 57 per ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: SHIONOGI TO ACQUIRE U.S. DRUGMAKER SCIELE PHARMA ...
AsiaPulse News;  September 2, 2008 ;     700+ words ...OSAKA, Sept 2 Asia Pulse - Shionogi & Co. (TSE:4507) on Monday announced plans to acquire U.S. firm Sciele Pharma Inc. for US$1.42 billion, or about 150 billion yen, as part of efforts to bolster its sales network in the world ...

Article: LifeCycle Pharma and Sciele Pharma Announce FDA ...
PR Newswire;  August 13, 2007 ;     700+ words ...- Sciele Pharma Expects U.S. Market Launch by the ... 2007 Summary: LifeCycle Pharma and Sciele Pharma announce FDA approval of fenofibrate ... mg. and 40 mg. dosage strengths. Sciele Pharma expects U.S. market launch by the ...

Article: Sciele Pharma Signs Exclusive Zovirax(R) ...
Business Wire;  December 20, 2006 ;     700+ words ...ATLANTA -- Sciele Pharma, Inc. (NASDAQ:SCRX), a specialty ... Under the terms of the agreement, Sciele Pharma will receive ongoing promotional ... President and Chief Executive Officer of Sciele Pharma, stated, "We are pleased to begin ...

Article: Sciele Pharma and Addrenex Pharmaceuticals Announce ...
Biotech Week;  May 13, 2009 ;     700+ words ...Sciele Pharma, a Shionogi Company, and Addrenex Pharmaceuticals ... compared to stimulant used alone (see also Sciele Pharma, Inc.). Larry Dillaha, M.D., Chief Medical Officer of Sciele Pharma, said, "We are pleased with the positive ...

Article: Morning Alert for Sciele Pharma Inc.
M2 Presswire;  May 14, 2007 ;     700+ words ... ... 14 May 2007-Biotech News: Morning Alert for Sciele Pharma Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:14052007 Morning Alert for Sciele Pharma Inc (NASDAQ:SCRX) Sciele Pharma, Inc. is a pharmaceutical company specializing ...

Article: Sciele Pharma, a Shionogi Company, to Acquire ...
Business Wire;  November 16, 2009 ;     700+ words ...ATLANTA -- Sciele Pharma, Inc.: * Provides Sciele with ... dermatology and pain management Sciele Pharma, Inc. (Head Office: Atlanta ... President and Chief Executive Officer of Sciele Pharma, said, "We are pleased to announce ...

Article: Sciele Pharma Raises 2006 and Reaffirms 2007 ...
Business Wire;  January 10, 2007 ;     700+ words ... ... President and Chief Executive Officer of Sciele Pharma, Inc. (NASDAQ:SCRX), raised ... 62. Mr. Fourteau reported that Sciele Pharma will begin promoting Zovirax ... half of 2007. In other developments, Sciele Pharma has completed the initial review of ...

Article: Sciele Pharma and Plethora Solutions Announce ...
Biotech Week;  August 12, 2009 ;     700+ words ...Sciele Pharma Inc.: Statistically and Clinically ... and Devoid of Systemic Side Effects Sciele Pharma Inc., a Shionogi Company, and Plethora ... and Distress domains) (see also Sciele Pharma, Inc.). This successful study ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives